Kendall Capital Management’s Labcorp LH Stock Holding History

Kendall Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,490	Closed	-$207K	–	113
2018 Q1	$207K	Buy	+1,490	New	+$219K	0.18%	100

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kendall Capital Management's LH Position: Q2 2018 in Review

Kendall Capital Management sold out of Labcorp (LH) in Q2 2018, closing a stake of 1,490 shares — an estimated $207K sold.

Kendall Capital Management first reported a position in LH in Q1 2018 and held it in 1 quarter. The position peaked at $207K in Q1 2018. 785 funds tracked by Wall St. Rank hold LH as of Q2 2018.

Kendall Capital Management reported no remaining Labcorp position as of Q2 2018 after selling out during the quarter.
Kendall Capital Management sold 1,490 Labcorp shares in Q2 2018, an estimated $207K.
Kendall Capital Management first reported a position in Labcorp in Q1 2018 and held it in 1 quarter.
Kendall Capital Management's Labcorp position peaked at $207K in Q1 2018.
785 funds tracked by Wall St. Rank held Labcorp as of Q2 2018.

Based on Kendall Capital Management's 13F filing for Q2 2018, filed 27 Jul 2018.